Author:
Cummings Matthew J.,Baldwin Matthew R.,Abrams Darryl,Jacobson Samuel D.,Meyer Benjamin J.,Balough Elizabeth M.,Aaron Justin G.,Claassen Jan,Rabbani LeRoy E.,Hastie Jonathan,Hochman Beth R.,Salazar-Schicchi John,Yip Natalie H.,Brodie Daniel,O’Donnell Max R.
Abstract
AbstractBackgroundNearly 30,000 patients with coronavirus disease-2019 (COVID-19) have been hospitalized in New York City as of April 14th, 2020. Data on the epidemiology, clinical course, and outcomes of critically ill patients with COVID-19 in this setting are needed.MethodsWe prospectively collected clinical, biomarker, and treatment data on critically ill adults with laboratory-confirmed-COVID-19 admitted to two hospitals in northern Manhattan between March 2nd and April 1st, 2020. The primary outcome was in-hospital mortality.Secondary outcomes included frequency and duration of invasive mechanical ventilation, frequency of vasopressor use and renal-replacement-therapy, and time to clinical deterioration following hospital admission. The relationship between clinical risk factors, biomarkers, and in-hospital mortality was modeled using Cox-proportional-hazards regression. Each patient had at least 14 days of observation.ResultsOf 1,150 adults hospitalized with COVID-19 during the study period, 257 (22%) were critically ill. The median age was 62 years (interquartile range [IQR] 51-72); 170 (66%) were male. Two-hundred twelve (82%) had at least one chronic illness, the most common of which were hypertension (63%; 162/257) and diabetes mellitus (36%; 92/257). One-hundred-thirty-eight patients (54%) were obese, and 13 (5%) were healthcare workers. As of April 14th, 2020, in-hospital mortality was 33% (86/257); 47% (122/257) of patients remained hospitalized. Two-hundred-one (79%) patients received invasive mechanical ventilation (median 13 days [IQR 9-17]), and 54% (138/257) and 29% (75/257) required vasopressors and renal-replacement-therapy, respectively. The median time to clinical deterioration following hospital admission was 3 days (IQR 1-6). Older age, hypertension, chronic lung disease, and higher concentrations of interleukin-6 and d-dimer at admission were independently associated with in-hospital mortality.ConclusionsCritical illness among patients hospitalized with COVID-19 in New York City is common and associated with a high frequency of invasive mechanical ventilation, extra-pulmonary organ dysfunction, and substantial in-hospital mortality.
Publisher
Cold Spring Harbor Laboratory
Reference30 articles.
1. Coronavirus disease-2019: cases in U.S. Atlanta: U.S. Centers for Disease Control and Prevention, April 11, 2020. (https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html). Accessed April 11th, 2020.
2. COVID-19 Tracker. Albany: New York State Department of Health, April 11, 2020. (https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n). Accessed April 11th, 2020.
3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
4. Clinical Characteristics of Coronavirus Disease 2019 in China
5. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy